Evaluation of Tramadol/Paracetamol versus placebo in reducing pain of Electromyography study
Phase 2
- Conditions
- pain.pain in limb
- Registration Number
- IRCT2012111011424N1
- Lead Sponsor
- Vice chancellor for research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Inclusion criteria includes: normal subject aged between 18-50 years.
Exclusion criteria includes: Epilepsy; Opioid hypersensitivity; Diabetes; Liver or Kidney dysfunction; Severe respiratory disease(asthma or Chronic Obstructive Pulmonary Disease); Opioid use or abuse; Selective Serotonin Reuptake Inhibitors or MAO inhibitor or analgesic use; Tricyclic Antidepressants or Neuroleptic use.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual Analog Scale (VAS) score. Timepoint: after and 2 hours after EMG. Method of measurement: estimation of pain severity on 100 scale.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: after and 2 hours after drug consumption. Method of measurement: asking patient.